Abbott Medical Danmark A/S: Financial statements 2024
CVR: 17558501
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Abbott Medical Danmark A/S (CVR 17558501) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 191,993,466 and a net result of DKK 7,897,543 compared with DKK 7,060,135 the year before. That is an increase of 3.3% compared with the year before. The profit margin was 4.1%. Equity in the 2024 report amounted to DKK 140,101,193. The solvency ratio was 74.7%. The company had 22 employees in the financial year.
- Revenue
- DKK 191,993,466
- Gross Profit
- DKK 35,548,715
- Profit/Loss
- DKK 7,897,543
- Equity
- DKK 140,101,193
- Total Assets
- DKK 187,554,394
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 192M | 35.5M | 7.9M | 140.1M | 22 |
| 2023 | 185.8M | 31.8M | 7.1M | 132.2M | 23 |
| 2022 | 188.1M | 32.6M | 4.1M | 125.1M | 24 |
| 2021 | 239.6M | 33.4M | 5.2M | 121.1M | 23 |
| 2020 | 214M | 32.2M | 5.3M | 115.9M | 23 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Abbott Medical Danmark A/S has published its annual report for 2023. Revenue came to DKK 185,830,596, and the net result was DKK 7,060,135.
As of April 18, 2024, Mika Tapio Mustonen has joined the board of directors of Abbott Medical Danmark A/S.
As of April 18, 2024, Flemming Wærn Johannessen has left the board of directors of Abbott Medical Danmark A/S.
As of April 18, 2024, Mika Tapio Mustonen is registered as director of Abbott Medical Danmark A/S.
As of April 18, 2024, Flemming Wærn Johannessen has stepped down as director of Abbott Medical Danmark A/S.
About Abbott Medical Danmark A/S
Abbott Medical Danmark A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 1994. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ST. JUDE MEDICAL DANMARK A/S and P.P.H.S.G. 209 A/S. The management consists of Mika Tapio Mustonen. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Mika Tapio Mustonen. The company is owned by ABBOTT LABORATORIES A/S. The company has 20 employees (2026). In 2025, the company reported revenue of DKK 198,838,342 and a net result of DKK 6,225,964 compared with DKK 7,897,543 the year before. Equity in the 2025 report amounted to DKK 46,327,156.
